Tempest Therapeutics, Inc. (TPST) Analyst Estimates Annual - Discounting Cash Flows
TPST
Tempest Therapeutics, Inc.
TPST (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2021
12-30
2017
12-30
2016
12-30
2015
12-30
Number of Analysts 1 1 1 1 0 0 14 7 12 9
Estimated Revenue
Low 117.7 4.3 57.82 17.85 0 0 0.11 0.398 0.659 0.399
Average 117.7 4.3 57.82 17.85 0 0 0.138 0.398 0.659 0.399
High 117.7 4.3 57.82 17.85 0 0 0.165 0.398 0.659 0.399
Estimated EBITDA
Low 0 0 0 0 0 0 -84.53 0 0 -85.94
Average 0 0 0 0 0 0 -70.44 0 0 -71.62
High 0 0 0 0 0 0 -56.36 0 0 -57.3
Estimated EBIT
Low 0 0 0 0 0 0 -85.14 0 0 -86.08
Average 0 0 0 0 0 0 -70.95 0 0 -71.73
High 0 0 0 0 0 0 -56.76 0 0 -57.38
Estimated Net Income
Low -118 -59.43 -63.62 -77.01 -170.2 -516.2 -87.71 -119,647 -204,033 -87.54
Average -118 -59.43 -63.62 -77.01 -170.2 -481.1 -73.09 -119,647 -204,033 -72.95
High -118 -59.43 -63.62 -77.01 -170.2 -446 -58.47 -119,647 -204,033 -58.36
Estimated SGA Expenses
Low 0 0 0 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0 0 0 0
Estimated EPS
Low -4.23 -2.13 -2.28 -2.76 -6.1 -18.5 -83.37 -4,288 -7,312 -596.3
Average -4.23 -2.13 -2.28 -2.76 -6.1 -17.49 -83.37 -4,288 -7,312 -596.3
High -4.23 -2.13 -2.28 -2.76 -6.1 -15.98 -83.37 -4,288 -7,312 -596.3
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program